Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3′-untranslated region of the prothrombin gene

被引:18
|
作者
Wulf, GM
Van Deerlin, VMD
Leonard, DGB
Bauer, KA
机构
[1] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02132 USA
[2] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA USA
关键词
thrombosis; mutation; factor V Leiden; prothrombin gene mutation;
D O I
10.1097/00001721-199903000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The factor V Leiden mutation and a guanine-to-adenine mutation at nucleotide 20210 in the 3'-untranslated region of the prothrombin gene are the most prevalent genetic defects in patients with deep venous thrombosis. Heterozygosity for the factor V Leiden and the prothrombin gene mutations is found in approximately 20 and 6% of unselected patients with deep venous thrombosis, respectively, whereas the prevalences of the two mutations in the general Caucasian population are approximately 6 and 2%, respectively. We evaluated an 18-year-old man presenting with a spontaneous episode of superficial venous thrombosis for the presence of an inherited thrombotic disorder. After excluding deficiencies of antithrombin, protein C, and protein S, genomic DNA from the patient was tested for the presence of the factor V Leiden and prothrombin gene mutations. Consanguinity was not present in the family. Genotyping demonstrated that the patient was homozygous for the factor V Leiden and prothrombin gene mutations. The likelihood of identifying an individual in the general population who is homozygous for both mutations similar to our patient is estimated to be less than 1 in 10 million. (C) 1999 Lippincote Williams & Wilkins.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 50 条
  • [31] Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation
    Vayá, A
    Todolí, J
    Ricart, J
    Estellés, A
    Mira, Y
    Villa, P
    Calabuig, JR
    Aznar, J
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (01) : 72 - 74
  • [32] Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation
    Gouin-Thibault, I
    Arkam, R
    Nassiri, S
    de la Tourette, A
    Conard, J
    Horellou, MH
    Elalamy, I
    Samama, MM
    THROMBOSIS RESEARCH, 2002, 107 (1-2) : 7 - 11
  • [33] Intra-atrial thrombosis and homozygous factor V Leiden mutation
    Simioni, P
    Scalia, D
    Tormene, D
    Bongiovi, S
    Sardella, C
    Girolami, A
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1997, 3 (03) : 215 - 217
  • [34] Association of the prothrombin G20210A mutation with factor V Leiden in a Midwestern American population
    Bavikatty, NR
    Killeen, AA
    Akel, N
    Normolle, D
    Schmaier, AH
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (02) : 272 - 275
  • [35] Internal jugular vein thrombosis in association with the factor V Leiden mutation
    Arullendran, P
    Jani, P
    Baglin, T
    Moffat, DA
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1998, 112 (04) : 383 - 386
  • [36] Successful Digital Revascularization in a Patient With Factor V Leiden Mutation
    Lineberry, Kyle
    Hoben, Gwendolyn
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2020, 45 (05): : 458.e1 - 458.e3
  • [37] Factor V Leiden, prothrombin G20210A and protein C mutation frequency in Turkish venous thrombosis patients
    Altinisik, Julide
    Ates, Omer
    Ulutin, Turgut
    Cengiz, Mujgan
    Buyru, Nur
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2008, 14 (04) : 415 - 420
  • [38] The common haemochromatosis mutation does not increase the risk of thrombosis in patients with factor V Leiden
    Banypersad, S
    Daly, ME
    Makris, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (03) : 842 - 843
  • [39] Post-Partum Ovarian Vein Thrombosis: Combined Effect of Infection and Factor V Leiden Mutation
    El Farran, H.
    Haddad, A. G.
    Radwan, A. H.
    Nassar, A. H.
    Hourani, R.
    Taher, Ali T.
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (01) : 80 - 81
  • [40] Tamoxifen and the Factor V Leiden Mutation
    Cuzick, Jack
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13) : 918 - U1